IRIDEX Corp (IRIX) USD0.01
IRIDEX Corporation is an ophthalmic medical technology company. The Company is focused on developing and commercializing of products to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, its laser consoles offer, glaucoma product line includes Cyclo G6, Micropulse P3 Probe, G-Probe and G-Probe Illuminate laser system used for the treatment of glaucoma. Medical Retina product line includes IQ 532 and IQ 577 laser photocoagulation systems used for the treatment of diabetic macular edema and other retinal diseases. Surgical Retina line of products includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLxlaser photocoagulation systems used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments. Its delivery devices offer txcell scanning laser delivery system (TxCell).
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.